Viewing Study NCT06340334

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:30 AM

Ignite Modification Date: 2025-12-27 @ 11:40 PM

Study NCT ID: NCT06340334

Status: NOT_YET_RECRUITING

Last Update Posted: 2024-04-01

First Post: 2024-03-25

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study

Sponsor: Nanjing First Hospital, Nanjing Medical University

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module